A deficiency in pejvakin, a protein of unknown function, causes a strikingly heterogeneous form of human deafness. Pejvakin-deficient (Pjvk À/À ) mice also exhibit variable auditory phenotypes. Correlation between their hearing thresholds and the number of pups per cage suggest a possible harmful effect of pup vocalizations. Direct sound or electrical stimulation show that the cochlear sensory hair cells and auditory pathway neurons of Pjvk À/À mice and patients are exceptionally vulnerable to sound. Subcellular analysis revealed that pejvakin is associated with peroxisomes and required for their oxidativestress-induced proliferation. Pjvk À/À cochleas display features of marked oxidative stress and impaired antioxidant defenses, and peroxisomes in Pjvk À/À hair cells show structural abnormalities after the onset of hearing. Noise exposure rapidly upregulates Pjvk cochlear transcription in wildtype mice and triggers peroxisome proliferation in hair cells and primary auditory neurons. Our results reveal that the antioxidant activity of peroxisomes protects the auditory system against noise-induced damage.
INTRODUCTION
Mutations of PJVK, which encodes pejvakin, a protein of unknown function present only in vertebrates, cause the DFNB59-recessive form of sensorineural hearing impairment. In the first patients described (Delmaghani et al., 2006) , the impairment was restricted to neurons of the auditory pathway, with auditory brainstem responses (ABRs) displaying abnormally decreased wave amplitudes and increased inter-wave latencies (Starr and Rance, 2015) . ABRs monitor the electrical response of auditory pathways to brief sound stimuli, from the primary auditory neurons synapsing with the sensory cells of the cochlea, the inner hair cells (IHCs), to the colliculus in the midbrain (Møller and Jannetta, 1983 ). However, some DFNB59 patients were found to have a cochlear dysfunction, as shown by an absence of the otoacoustic emissions (OAEs) that are produced by the outer hair cells (OHCs), frequency-tuned cells endowed with electromotility that mechanically amplify the sound stimulation of neighboring IHCs (Ashmore, 2008) . These patients had truncating mutations of PJVK, whereas the previously identified patients, with extant OAEs, had missense mutations (p.T54I or p.R183W) (Ebermann et al., 2007; Schwander et al., 2007; Borck et al., 2012) . However, the identification of patients also carrying the p.R183W missense mutation but lacking OAEs (Collin et al., 2007) refuted any straightforward connection between the nature of the PJVK mutation and the hearing phenotype. The severity of deafness in DFNB59 patients varies from moderate to profound and may even be progressive in some patients, suggesting that extrinsic factors may influence the hearing phenotype.
We investigated the role of pejvakin, with the aim of determining the origin of the phenotypic variability of the DFNB59 form of deafness. Our study of Pjvk knockout mouse models and of patients revealed an unprecedented hypervulnerability of auditory hair cells and neurons to sound exposure, accounting for phenotypic variability. We found that pejvakin is a peroxisome-associated protein involved in the oxidative-stress-induced proliferation of this organelle. Pejvakin-deficient mice revealed the key role of peroxisomes in the redox homeostasis of the auditory system and in the protection against noise-induced hearing loss.
RESULTS

Heterogeneity in the Hearing Sensitivity of Pjvk À/À Mice
We generated pejvakin-null (Pjvk À/À ) mice carrying a deletion of Pjvk exon 2, resulting in a frameshift at codon position 71 (p.Gly71fs*9) ( Figure S1 ; see the Supplemental Experimental Procedures). ABR thresholds recorded on postnatal day 30 (P30) Pjvk À/À mice (n = 48) ranged from 35 to 110 dB SPL (sound pressure level) at 10 kHz but never exceeded 30 dB SPL in their Pjvk +/+ littermates (n = 26) ( Figure 1A ). This broad range of hearing sensitivity in Pjvk À/À mice, from near-normal hearing to almost complete deafness, extended across the whole frequency spectrum. The thresholds of distortion-product OAEs (DPOAEs) at 10 kHz (i.e., the minimum stimulus required for DPOAEs production by OHCs) also fell within an abnormally large range of values, from 30 to 75 dB SPL, in 28 Pjvk
mice, indicating an OHC dysfunction, and DPOAEs were undetectable in another 20 Pjvk À/À mice, suggesting a complete OHC defect ( Figure 1B ). The absence of pejvakin in mice thus results in a puzzlingly large degree of hearing phenotype variability.
Hypervulnerability to the Natural Acoustic Environment in Pjvk À/À Mice
We investigated the variability of Pjvk À/À auditory phenotypes, by first determining the ABR thresholds of Pjvk À/À littermates from different crosses. Large differences were observed between crosses, with much fewer differences between the Pjvk
littermates of individual crosses. Litters with larger numbers of pups (6 to 12) had higher ABR thresholds, suggesting that the natural acoustic environment, with the calls of larger numbers of pups, might be deleterious in Pjvk À/À mice. Pups are vocally very active from birth to about P20. We manipulated the level of exposure to pup calls by randomly splitting large litters of Pjvk À/À pups into groups of 2, 4, 6 and 10 pups per cage, with foster mothers, before P10, i.e., several days before hearing onset. The ABR thresholds at P21 were significantly correlated with the number of pups raised together (p < 0.001, r 2 = 0.51) ( Figure 1C ). We then evaluated the effect of a controlled sound stimulation on hearing, by presenting 1,000 tone bursts at 10 kHz, 105 dB SPL (2-ms plateau stimulations separated by 60-ms intervals of silence), energetically equivalent to a 3-min stay in the natural environment of a 12-pup litter, while monitoring the ABRs during sound exposure. These conditions are referred to hereafter as ''controlled sound exposure.'' We probed the effect of sound exposure by ABR tests, which, limited to 50 repetitions of tone bursts, did not influence the hearing thresholds of Pjvk À/À mice. In a sample of P30 Pjvk À/À mice with initial ABR threshold elevation (below 35 dB SPL), controlled sound exposure affected ABR thresholds in the 12-20 kHz frequency interval (corresponding to the cochlear zones in which hair-cell stimulation was strongest), with an immediate increase of 21.7 ± 10.3 dB (n = 8; p < 0.001), not observed in Pjvk +/+ mice (2.2 ± 2.4 dB, n = 12; p = 0.3) ( Figure 1D ). Pjvk À/À mice transferred to a silent environment after exposure displayed a further increase of 33.7 ± 16.0 dB (n = 8) 2 days after exposure. The threshold shift decreased to 23.7 ± 18.0 dB at 7 days, and disappeared entirely by 14 days. When exposed mice were returned to the box with their littermates, their ABR continued to increase, at a rate of 15 dB per week. Pejvakin deficiency thus results in particularly high levels of vulnerability to low levels of acoustic energy, and the increase in ABR thresholds is reversible but only slowly and in a quiet environment. (B) DPOAE thresholds at 10 kHz in P30 Pjvk +/+ (n = 14 mice) and Pjvk À/À (n = 48 mice) littermates. In ears with no DPOAE, even at 75 dB SPL (the highest sound intensity tested), DPOAE thresholds were arbitrarily set at 80 dB SPL.
(C) Relationship between the number of pups raised together (determining sound levels in the immediate environment) and ABR thresholds at 10 kHz in P21 Pjvk À/À pups. Inset: a time-frequency analysis of a mouse pup's vocalization. Pup calls from P0 to P21 form harmonic series of about 5 kHz, with the most energetic harmonic at about 10 kHz. In a 12-pup litter, call levels reach 105 ± 5 dB SPL at the entrance to the ear canals of the pups. (D) ABR thresholds at 10 kHz in P30 Pjvk +/+ and Pjvk À/À mice before (dots) and after (crosses) controlled sound exposure. ns, not significant; ***p < 0.001. See also Figure S1 . DPOAEs (n = 8; p < 0.0001), and an increase in DPOAE threshold, but it had no effect on the DPOAEs of Pjvk +/+ mice (n = 9; p = 0.51) ( Figure 2B ). OHCs lacking pejvakin are thus also hypervulnerable to sound. We investigated the effect of the absence of pejvakin on the auditory pathway by comparing electrically evoked brainstem responses (EEBR) Figures 2H and 2I) . Likewise, the latency interval between ABR wave I and wave IV (the counterpart of wave E IV), abnormal in one-third of the Pjvk À/À mice tested (with an ABR threshold < 95 dB SPL, n = 12) (Figures 2C and 2E) , got abnormal in all of them after controlled sound exposure (0.16 ms further increase; paired t test, p < 0.001). By contrast, it remained normal in Pjvk fl/fl Myo15-cre +/À mice (n = 10 ears; p = 0.73) ( Figures 2C  and 2F) . Thus, the absence of pejvakin affects the propagation of action potentials in the auditory pathway after both controlled electrical and sound exposure in the Pjvk À/À mice.
To clarify whether these abnormalities were of neuronal or glial origin, we performed a rescue experiment in Pjvk À/À mice, using adeno-associated virus 8 (AAV8) vector-mediated transfer of the murine pejvakin cDNA (AAV8-Pjvk). AAV8 injected into the cochlea transduces the primary auditory neurons (cochlear ganglion neurons) and neurons of the cochlear nucleus ( Figure S2A ), but not the hair cells. All Pjvk À/À mice (n = 7) injected on P3 and tested on P21 had normal ABR interwave I-IV latencies (Figure 2J) , and their EEBR wave-E IV amplitude was insensitive to controlled electrical stimulation (1.91 ± 0.97 mV before and 1.87 mV ± 1.07 after stimulation; paired t test, p = 0.59) ( Figures  2K and 2L ). The absence of pejvakin thus renders auditory pathway neurons hypervulnerable to exposure to mild, short sound stimuli.
Hypervulnerability to Sound in DFNB59 Patients
We then investigated whether the hearing of DFNB59 patients was also hypervulnerable to sound exposure. We tested five patients carrying the p.T54I mutation (Delmaghani et al., 2006) . Transient-evoked OAEs (TEOAEs) assessing OHC function over a broad range of frequencies were detected for all ears, despite the severe hearing impairment (hearing threshold increasing from 66 dB HL at 250 Hz to 84 dB at 8 kHz). Following minimal exposure to impulse stimuli (clicks at 99 dB nHL), ABR waves were clearly identified in response to 250 clicks. When exposure was prolonged to 1,000 clicks (the standard procedure), wave V, the equivalent of mouse ABR-wave IV, which was initially conspicuous, displayed a decrease in amplitude (to 39% ± 30% of its initial amplitude) and an increase in latency (of 0.30 ± 0.15 ms) ( Figures 3A, 3C , and 3D). In parallel, the I-V interwave interval increased by 0.30 ± 0.15 ms. Wave-V amplitude and latency recovered fully after 10 min of silence ( Figure 3B ). In control patients with sensorineural hearing impairment of cochlear origin matched for ABR thresholds, similar sound stimulation did not affect ABR wave-V amplitude (105% ± 14% of the initial amplitude after exposure; n = 13 patients) or latency (À0.02 ± 0.07 ms change after exposure) (Figures 3C and 3D) . Exposure of the DFNB59 patients to 1,000 clicks also affected TEOAEs (6.1 ± 5.2 dB nHL decrease in amplitude; paired t test, p = 0.02). Therefore, as in pejvakin-deficient mice, the cochlear and neuronal responses of DFNB59 patients were affected by exposure to low-energy sound.
Redox Status Abnormalities and ROS-Induced Cell Damage in the Cochlea of Pjvk À/À Mice
We studied the Pjvk À/À cochlea by light microscopy on semithin sections and electron microscopy. On P15 and P21, both OHCs and IHCs were normal in number and shape. Their hair bundles (the mechanoreceptive structures responding to sound), the ribbon synapses of the IHCs, and their primary auditory neurons were unmodified (data not shown). On P30, we observed the loss of a few OHCs (16% ± 11%, n = 5 mice), restricted to the basal region of the cochlea (tuned to high-frequency sounds). From P30 onward, OHCs, cochlear ganglion neurons, and then IHCs disappeared, and the sensory epithelium (organ of Corti) progressively degenerated ( Figure S3A ). 
(legend continued on next page)
We investigated possible changes in gene expression in the organ of Corti of P15 Pjvk À/À mice, by microarrays (see the Supplemental Experimental Procedures). Eighteen genes had expression levels at least 1.5-fold higher or lower in Pjvk À/À mice than in Pjvk +/+ mice. Marked differences were observed for four genes involved in the redox balance-CypA, Gpx2, cDct, and Mpv17-encoding cyclophilin A, glutathione peroxidase 2, c-dopachrome tautomerase, and Mpv17, respectively (Table S1 ). All of these genes were downregulated in Pjvk
mice, a result confirmed by qRT-PCR ( Figure S4A ), and all encode antioxidant proteins, suggesting that Pjvk À/À mice have impaired antioxidant defenses (Table S1 ). We thus assessed the level of oxidative stress in the cochlea of P21 Pjvk À/À mice, by determining the ratio of reduced to oxidized glutathione (GSH:GSSG). The GSSG content was about three times larger than in Pjvk +/+ mice, whereas the GSH content was 23% smaller, resulting in a GSH:GSSG ratio in Pjvk À/À cochleas reduced by a factor of 3.4 ( Figure 4A ). Pejvakin deficiency thus results in cochlear oxidative stress. We assessed lipid peroxidation by reactive oxygen species (ROS) in Pjvk À/À mice, by immunofluorescence-based detection of the by-product 4-hydroxy-2-nonenal (4-HNE). Strong immunoreactivity was observed in P60 Pjvk À/À hair cells and cochlear ganglion neurons ( Figure S3B ). Quantification of lipid peroxidation in microdissected organs of Corti from P30 Pjvk À/À and Pjvk +/+ mice, showed a moderate, but statistically significant, increase of the malondialdehyde content in the absence of pejvakin (2.15 ± 0.14 mM in Pjvk À/À versus 1.84 ± 0.11 mM in Pjvk +/+ mice; p = 0.04). Thus, pejvakin deficiency led to impaired antioxidant defenses in the cochlea, resulting in ROS-induced cell damage. We then studied electrophysiological features of IHCs and OHCs in the mature cochlea of P19-P21 Pjvk À/À mice. In IHCs, the number of synaptic ribbons, Ca 2+ currents, and synaptic exocytosis were unaffected ( Figure S5A ). We investigated whether Pjvk À/À mice display the main K + currents found in mature IHCs, specifically I K,f , which plays a major part in IHC repolarization and is involved in the high temporal precision of action potentials in postsynaptic nerve fibers, I K,s , and I K,n (Oliver et al., 2006) . The I K,f current that flows through the large conductance voltage-and Ca
2+
-activated potassium (BK) channels, a well-known target of ROS (Tang et al., 2004) , was detected in only 4 out of 11 Pjvk À/À IHCs, and the mean number of spots immunolabeled for the BK a-subunit per IHC was much lower in Pjvk À/À mice (5.0 ± 1.4, n = 283 IHCs from seven mice) than in Pjvk +/+ mice (13.9 ± 2.6, n = 204 IHCs from nine mice; t test, p < 0.001). By contrast, the I K,s and I K,n currents were not affected ( Figures 4B and S5B ). The electromotility of OHCs was moderately impaired in Pjvk À/À mice ( Figure S5C ). This contrasted with the total loss of DPOAE in a large majority of Pjvk À/À mice from P15 on, even at the highest possible stimulus level of 75 dB SPL. It thus pinpointed the existence of an additional defect, likely a mechanoelectrical transduction defect, the main determinant of DPOAEs at high stimulus levels (Avan et al., 2013) . The decrease of the cochlear microphonic potential that reflects mechanoelectrical transduction currents through OHCs of the basal-most cochlear region, indeed corroborated the DPOAE measurements: this potential, recorded for a 5-kHz sound stimulus at 95 dB SPL, was always larger than 10 mV in Pjvk +/+ mice (n = 8), but fell between 5 and 3 mV in the P21 Pjvk À/À mice with residual DPOAEs (n = 2), and below 1 mV, in the Pjvk À/À mice without persisting DPOAEs (n = 6). Taken together, oxidative stress in the Pjvk À/À cochlea impacts various electrophysiological properties of the hair cells, particularly mechanoelectrical transduction and K + current through BK channels.
Mitochondrial defects are a common cause of ROS overproduction. However, we did not find evidence that mitochondria were damaged, as vulnerability of the mitochondrial membrane potential, Dc m , to the uncoupler carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) Figure S6A ) and in the human HepG2 hepatoblastoma cell line, which is particularly rich in this organelle ( Figure 5A ). The specificity of the Pjvk-G21 antibody was demonstrated by the immunolabeling of peroxisomes in the hair cells of Pjvk Myo15-cre +/À mice ( Figures 5B and S6B ). Prediction programs failed to detect the PTS1 or PTS2 motifs in the pejvakin sequence (Mizuno et al., 2008) , the targeting signals for the importation of peroxisomal matrix proteins into the organelle (Smith and Aitchison, 2013) , suggesting that pejvakin is a peroxisomal membrane or membrane-associated protein.
Structural Abnormalities of Peroxisomes in the Hair Cells of Pjvk
We investigated the distribution and morphology of peroxisomes by TEM. Peroxisomes were identified on the basis of catalase activity detection using 3,3 0 -diaminobenzidine as substrate. We focused on OHCs, the first to display a dysfunction in Pjvk À/À mice. On P30, but not on P15, both the distribution and shape of peroxisomes differed between Pjvk À/À and Pjvk +/+ mice (Figure 5E ). In Pjvk +/+ OHCs, the peroxisomes were restricted to an area immediately below the cuticular plate. In Pjvk À/À mice, the peroxisomes located just below the cuticular plate were slightly larger than those in Pjvk +/+ mice. Strikingly, irregular catalase-containing structures, some of which were juxtaposed, were present in the perinuclear region, in the immediate vicinity of the nuclear membrane of all Pjvk À/À OHCs, but not of Pjvk +/+ OHCs ( Figure 5E ). The lack of pejvakin thus results in peroxisome abnormalities in OHCs after the onset of hearing.
Pejvakin Is Involved in Oxidative Stress-Induced Peroxisome Proliferation In HepG2 cells, protrusions emerging from some peroxisomes, the first step of peroxisome biogenesis from pre-existing peroxisomes, were immunoreactive for pejvakin. String-of-beads structures corresponding to elongated and constricted peroxisomes, preceding final fission (Smith and Aitchison, 2013) , were also pejvakin-immunoreactive, suggesting a role for this protein in peroxisome proliferation ( Figure S6C ). Peroxisomes actively contribute to cellular redox balance, by producing and scavenging/degrading H 2 O 2 through a broad spectrum of oxidases and peroxidases (especially catalase), respectively (Schrader and Fahimi, 2006 S7A ). We then asked whether mutations reported in DFNB59 patients also affect peroxisome proliferation. We assessed the number of peroxisomes in transfected HeLa cells producing EGFP alone, EGFP and murine pejvakin, or EGFP and one of the mutated forms of murine pejvakin carrying the mutations responsible for DFNB59 (p.T54I, p.R183W, p.C343S, or p.V330Lfs*7). Cells producing the non-mutated pejvakin had larger numbers of peroxisomes than cells producing EGFP alone, whereas cells producing any of the mutated forms of pejvakin (mutPjvk-IRES-EGFP) had smaller peroxisome numbers. In addition, many of these cells contained enlarged peroxisomes, a feature typical of peroxisome proliferation disorders (Figure 5D and S7B). Together, these results strongly suggest that pejvakin is directly involved in the production of new peroxisomes from pre-existing peroxisomes.
Upregulation of Pjvk Cochlear Transcription and Peroxisome Proliferation in Response to Sound
We then asked whether pejvakin is involved in the physiological response to sound. We first assessed the transcription of Pjvk and of CypA, Gpx2, c-Dct, and Mpv17, which were downregulated in Pjvk À/À mice, in microdissected organs of Corti from P21 wild-type mice, with or without prior sound stimulation (5-20 kHz, 105 dB SPL for 1 hr; see the Supplemental Experimental Procedures). Transcript levels were analyzed by qRT-PCR at various times (1, 3, 6, and 18 hr) after sound exposure ( Figure 6A ). Pjvk transcript levels had increased by factors of 1.9 ± 0.1 and 3.5 ± 0.7, mean ± SEM, after 1 and 6 hr, respectively. CypA, cDct, and Mpv17 were also upregulated after 6 hr (by factors of 6.6 ± 1.2, 4.3 ± 0.6, and 1.5 ± 0.1, respectively), as were c-Fos and Hsp70, used as a positive control, but not Gpx2. Thus, noise exposure leads to an upregulation of the transcription of Pjvk and of genes downregulated in Pjvk À/À mice, and this effect is dependent on acoustic energy level of the stimulation ( Figure S4B ). This result predicted that sound exposure would lead to peroxisome proliferation in the auditory system of wild-type mice. 6 hr after exposure (5-20 kHz, 105 dB SPL for 1 hr), the numbers of peroxisomes were unchanged (34.5 ± 0.8 and 35.9 ± 1.0, mean ± SEM, per IHC from unexposed and soundexposed mice, respectively, n = 75 cells from six mice; t test, p = 0.25). However, at 48 hr, they had markedly increased, by a factor of 2.3, in both IHCs and OHCs (84.7 ± 5.0 per IHC and 16.5 ± 1.0 per OHC, n = 90 cells and n = 150 cells from six mice, respectively) compared to unexposed mice (36.8 ± 3.0 per IHC and 7.3 ± 0.4 per OHC, n = 90 cells and n = 150 cells from six mice, respectively; t test, p < 0.0001 for both comparisons). The number of peroxisomes had also increased, by 35%, in the dendrites of primary auditory neurons (1.7 ± 0.1 and 2.3 ± 0.2 peroxisomes per micrometer of neurite length, n = 40 neurites from five unexposed and five sound-exposed Pjvk +/+ mice, respectively; t test, p = 0.003) ( Figure 6B ).
Therapeutic Approaches in Pjvk À/À Mice
Based on these results, we tested whether the classical antioxidant drug N-acetyl cysteine (NAC) (either alone or associated with a-lipoic acid and a-tocopherol; see the Supplemental Experimental Procedures) administered to Pjvk À/À pups could improve their hearing. The ABR thresholds of P21 NACtreated Pjvk À/À pups (n = 21) were about 10 dB lower than those of untreated Pjvk À/À pups (n = 24) for all frequencies tested (t test, p < 0.001 for all comparisons) ( Figure 7A ). The amplitude of the ABR wave I elicited at 105 dB SPL (4.35 ± 1.16 mV, n = 21) was the same as that of Pjvk +/+ mice (4.36 ± 1.15 mV, n = 18; t test, p = 0.97) and greater than that of untreated Pjvk À/À mice (1.88 ± 1.07 mV, n = 24; t test, p < 0.001) ( Figure 7B ). EEBRs were more resistant to the high-rate electrical stimulation in treated than in untreated mutant mice ( Figure 7C ). Conversely, NAC had no beneficial effect on OHCs (data not shown). The association of NAC with a-lipoic acid and a-tocopherol did not perform any better (data not shown).
Full recovery of the neuronal phenotype was achieved by the intracochlear injection of AAV8-Pjvk (see above). As hair cells are not transduced by AAV8, we investigated whether AAV2/8, which transduces hair cells only ( Figure S2B ), could rescue the Pjvk À/À hair-cell phenotype. The auditory function of Pjvk À/À mice (n = 7, four pups per cage in every experiment) receiving intracochlear injections of AAV2/8-Pjvk-IRES-EGFP on P3 was assessed on P21, and the percentage of transduced IHCs and OHCs was evaluated in each injected and contralateral (not injected) cochlea, on the basis of EGFP fluorescence. Improvements in ABR thresholds of 20 to 30 dB SPL with respect to untreated mice were observed for frequencies between 10 and 20 kHz (t test, p < 0.001 for all comparisons; Figure 7D ). Upon injection of AAV2/8-EGFP, DPOAEs, ABR thresholds, and ABR wave I amplitude and latency were similar to those of untreated Pjvk À/À mice (data not shown). A partial reversion of the OHC dysfunction was obtained, with detectable DPOAEs in pejvakin cDNA-treated cochleas (threshold 54.0 ± 10.7 dB), but not in contralateral, untreated cochleas ( Figure 7E ). DPOAE thresholds were linearly correlated (r 2 = 0.74, p < 0.001) with the number of EGFP-tagged OHCs ( Figure 7F ), suggesting that the normalization of DPOAE thresholds may be possible if all OHCs could be transduced. The latency of the ABR wave I in response to a 105 dB SPL stimulation decreased significantly (1.38 ± 0.11 ms for the treated ears; n = 6, versus 1.53 ± 0.10 ms for the contralateral, untreated ears; paired t test, p = 0.03) ( Figure 7G ), and its amplitude increased into the normal range (7.34 ± 0.80 mV versus 2.93 ± 0.92 mV; paired t test, p < 0.001) ( Figure 7H ), in relation to the number of EGFP-tagged IHCs (r 2 = 0.89 for wave I amplitude, p < 0.001; Figure 7I ). No correction of the interwave I-IV latency was observed, as expected (data not shown).
Finally, we investigated the effect of the transduction of Pjvk À/À IHCs by AAV2/8-Pjvk-IRES-EGFP on their peroxisomes.
33% more peroxisomes in cells producing both EGFP and Pjvk (n = 200) than in cells producing EGFP alone (n = 150). Right panel: for every range of enlarged peroxisome size, x (0.6-0.8 mm, 0.8-1.0 mm, and >1.0 mm), in two perpendicular directions, the proportion of cells containing at least one peroxisome. See also Figure S7B . . Peroxisomes were counted 48 hr after sound exposure. OHCs, IHCs, and neuronal processes stained for F-actin, myosin VI, and neurofilament protein NF200, respectively. In OHCs and IHCs, the peroxisomes are located below the CP and throughout the cytoplasm, respectively. For OHCs, both a lateral view and a transverse optical section at the level of CP (scheme on the right) are shown. The number of peroxisomes was increased in OHCs, IHCs, and dendrites after sound exposure. N, cell nucleus. ***p < 0.001. Error bars represent the SEM. Scale bars are 5 mm. See also Figure S4 and Table S1 .
Before sound exposure, the numbers of peroxisomes in IHCs of P21 Pjvk and four AAV2/8-Pjvk Pjvk À/À mice, and n = 90 cells from six Pjvk +/+ mice, respectively; t test, p = 0.11 and p = 0.30, respectively). By contrast, 48 hr after sound exposure (5-20 kHz) at 105 dB SPL for 1 hr, the number of peroxisomes had decreased by 63% in Pjvk À/À IHCs (30.5 ± 1.9 and 11.2 ± 1.3 peroxisomes per IHC, n = 75 cells from five unexposed and five sound-exposed Pjvk À/À mice, respectively; t test, p < 0.0001), and enlarged PMP70-labeled structures were present close to the nucleus ( Figure 7J ). In response to the same sound but of a lower intensity, i.e., 97 dB SPL for 1 hr, the number of peroxisomes was unchanged in Pjvk À/À IHCs (30.5 ± 1.9 and 34.6 ± 2.3 peroxisomes per IHC, n = 60 cells from four unexposed and four sound-exposed Pjvk À/À mice, respectively; t test, p = 0.17), and no enlarged PMP70-stained structures were detected (data not shown). The absence of pejvakin thus resulted in defective sound-induced peroxisomal proliferation (both at 105 dB SPL and 97 dB SPL) and, even, in peroxisome degeneration (at 105 dB SPL) in IHCs. In Pjvk À/À mice injected with AAV2/8-Pjvk-IRES-EGFP on P3 and exposed to 105 dB SPL for 1 hr on P21, enlarged PMP70-labeled structures were no longer detected in transduced IHCs, and the number of peroxisomes increased by 35% (32.3 ± 2.1 and 43.7 ± 3.0 peroxisomes per IHC, n = 60 cells from unexposed and exposed transduced Pjvk À/À IHCs, respectively; t test, p = 0.002) (Figure 7J) . We conclude that pejvakin re-expression fully protects Pjvk À/À IHCs from the degenerescence of peroxisomes and partially restores their impaired adaptive proliferation.
DISCUSSION
Noise-induced hearing loss (NIHL) is the second most common form of sensorineural hearing impairment after presbycusis in the United States (Dobie, 2008) . Here, we describe a genetic form of NIHL, by showing that pejvakin deficiency in mice and DFNB59 patients leads to hypervulnerability to sound, due to a peroxisomal deficiency. To our knowledge, a peroxisomal cause of an isolated (non-syndromic) form of inherited deafness has not been reported yet. The peroxisome emerges as a key organelle in the redox homeostasis of the auditory system, for coping with the overproduction of ROS induced by high levels of acoustic energy. Acoustic energy is the main determinant of NIHL. The L EX,8 hr (for level of exposure over an 8-hr workshift) index has been defined such that an L EX,8 hr of X dB delivers the same energy as a stable sound of X dB played over a period of 8 hr. Chronic occupational exposures to less than 85 dB (or 80 dB, depending on the country) are deemed safe. In Pjvk À/À mice, a single exposure to 63 dB L EX,8 hr increased hearing thresholds by 30 dB, with full recovery occurring after about 2 weeks. By contrast, a ten times more energetic exposure to a L EX,8 hr of 73 dB in wildtype mice of the same strain produces only an 18 dB shift in threshold, with a recovery time of 12 hr (Housley et al., 2013) . This hypersensitivity of Pjvk À/À mice to noise suggests that the L EX,8 hr of about 83 dB for a cage of ten pups is sufficient to account for permanent hearing loss in these Pjvk À/À pups, while some of those housed in small numbers in quiet rooms can display near-normal hearing thresholds (see Figure 1C) . Likewise, the auditory function of DFNB59 patients was transiently affected by a 57 dB L EX,8 hr exposure, routinely used in ABR tests. NIHL involves the excessive production of ROS, overwhelming the antioxidant defense system and causing irreversible oxidative damage to DNA, proteins, and lipids within the cell (Henderson et al., 2006) . Noise-induced oxidative stress results in the production of H 2 O 2 and other ROS as by-products, thought to derive from the intense solicitation of mitochondrial activity, and several mouse mutants with mitochondrial defects are prone to NIHL (Ohlemiller et al., 1999; Brown et al., 2014) . Our studies of pejvakindeficient mouse mutants and rescue experiments targeting the hair cells and auditory neurons unambiguously show that IHCs, OHCs, primary auditory neurons, and neurons of the cochlear nucleus are hypervulnerable to sound in the absence of pejvakin, which is consistent with previous results showing that hair cells and neurons of the auditory system are targets of NIHL (Wang et al., 2002; Kujawa and Liberman, 2009; Imig and Durham, 2005) . However, our study goes one step further by implicating a possible common mechanism: peroxisomal failure, the importance of which is demonstrated by the impairment of the redox homeostasis caused by pejvakin deficiency. It also reveals a major cause of the unusually high level of phenotypic variability observed in pejvakin-deficient mice and humans: the difference in sound exposure and the inability of the peroxisomes to cope with the resultant activity-dependent oxidative stress in the absence of pejvakin. Incidentally, this can account for the apparent paradox that mice carrying the R183W mutation in pejvakin displayed a much more severe neural pathway defect than the Pjvk À/À mice (Delmaghani et al., 2006) . Due to the preservation of hair cell functions, the auditory neurons of R183W mutant mice should be strongly stimulated, whereas the early permanent damage to cochlear hair cells in Pjvk À/À mice acts as a protective ''muffler'' of the neuronal pathway. In mammals, the number and metabolic functions of peroxisomes differ between cell types. However, all cell types are able to adapt rapidly to modifications in physiological conditions by changing the number, shape, size, and molecular content of peroxisomes, resulting in considerable functional plasticity of these organelles (Schrader et al., 2012; Smith and Aitchison, 2013) . Our experiments on Pjvk À/À and Pjvk +/+ mouse embryonic fibroblasts stressed with H 2 O 2 showed that pejvakin is critically involved in the oxidative stress-induced proliferation of peroxisomes through growth and fission of pre-existing peroxisomes. The molecular machinery underlying this adaptive process is still poorly understood beyond the involvement of Pex11a (Li et al., 2002) . Of note, the absence of pejvakin only affects the proliferation of peroxisomes from pre-existing peroxisomes, but not the constitutive biogenesis of this organelle. Accordingly, structural abnormalities of peroxisomes in Pjvk À/À mice became apparent only after hearing onset, in the context of the oxidative stress produced by noise exposure. By contrast, the PEX gene defects causing Zellweger syndrome spectrum (ZSS) disorders and rhizomelic chondrodysplasia punctata affect the constitutive biogenesis of peroxisomes. Hearing impairment in ZSS disorders involves a severe impairment of neuronal conduction and has been attributed to defects in the synthesis of two essential myelin sheath componentsplasmalogens and docosahexaenoic acid-which is critically dependent on peroxisomes. Our results suggest that ZSS also includes a defective redox balance in the hair cells and neurons of the auditory system. In the context of noise exposure, the upregulation of Pjvk transcription in the cochlea and the subsequent peroxisome proliferation in the hair cells and auditory neurons of wild-type mice suggest that pejvakin-dependent peroxisome proliferation in the auditory system is part of the physiological response to high levels of acoustic energy that result in increased amounts of ROS. This and the marked oxidative stress detected in the Pjvk À/À cochlea imply that the proliferation of peroxisomes plays an antioxidant role, similar to that reported in other cell types (Santos et al., 2005; Diano et al., 2011) . The rapid elevation of the hearing threshold in Pjvk À/À mice in response to low-energy sounds and the increase in interwave I-IV latency observed in DFNB59 patients within a few seconds are consistent with an activity-dependent H 2 O 2 production that, due to impaired cellular redox homeostasis, results in concentrations of H 2 O 2 high enough to impact on the activity of various target proteins including ion channels and transporters (Rice, 2011) . The worsening of hearing sensitivity, 2 days later, in the mutant mice lacking pejvakin, exacerbated by putting back the mice in a noisy environment, fits the picture of the absence of sound-induced biogenesis of peroxisomes (with their degeneration occurring in a high acoustic energy environment). We thus conclude that the hypervulnerability of Pjvk À/À mice and DFNB59 patients to sound does not result simply from an exacerbation, by sound, of a pre-existing redox-balance defect, but is the consequence of impaired adaptive proliferation of peroxisomes in the absence of pejvakin. Both defective peroxisome proliferation in IHCs of Pjvk À/À mice in response to sound exposure and its partial recovery by pejvakin cDNA transfer support this conclusion. A full recovery of the adaptive peroxisome proliferation produced by sound exposure may require higher concentrations of pejvakin or the sound-induced modulation of Pjvk transcription (see Figure 6A ), which was missing in our rescue experiments (pejvakin cDNA expression being driven by a constitutive promoter). In patients with hearing impairment, the amplification of sound by hearing aids or direct electrical stimulation of the auditory nerve by a cochlear implant delivers a stimulus with an energy level similar to that shown here to worsen the hearing impairment of Pjvk À/À mice within 1 min of sound exposure. Therefore, in cases of peroxisomal deficiency, as in DFNB59, specific protection against redox homeostasis failure is essential. Patients with such conditions should avoid noisy environments and a beneficial effect of hearing devices should require an antioxidant protection. N-acetyl cysteine was the only antioxidant drug tested here to display some, albeit limited, efficacy. By contrast, AAV-mediated gene therapy could potentially provide full protection. Finally, deciphering the sound-stress-induced protective signaling pathway involving pejvakin might lead to the discovery of therapeutic agents for NIHL.
EXPERIMENTAL PROCEDURES Audiological Studies in Mice
Auditory tests were performed in an anechoic room, on anesthetized animals whose core temperatures were maintained at 37 C (see the Supplemental
Experimental Procedures).
Audiological Tests in Patients
Informed consent was obtained from all the subjects included in the study. Pure-tone audiometry was performed with air-and bone-transmitted tones. Hearing impairment was assessed objectively, by measuring ABRs and transient-evoked otoacoustic emissions (TEOAEs). The nonlinear TEOAE recording procedure was used (derived from the ILO88 system), making it possible to extract TEOAEs from linear reflection artifacts from the middle ear, and to evaluate background noise. TEOAE responses were analyzed in 1-kHz-wide bands centered on 1, 2, 3 and 4 kHz.
Generation of an Anti-pejvakin Monoclonal Antibody
The 3 0 end of the coding sequence of the Pjvk cDNA (NCBI:NM_001080711.2) was inserted into a pGST-parallel-2 vector (derived from pGEX-4T-1; Amersham). The resultant construct, encoding the C-terminal region of pejvakin (residues 290-352; RefSeq:NP_001074180.1) fused to an N-terminal glutathione S-transferase tag, was introduced into Escherichia coli BL21-Gold (DE3)-competent cells (Stratagene). The pejvakin protein fragment was purified on a glutathione-Sepharose 4B column, then subjected to size-exclusion chromatography and used as the antigen for immunization. Antibodies were produced by immunizing Pjvk À/À mice. An immunoglobulin G monoclonal antibody (K D of 6 3 10 À8 M), Pjvk-G21, was selected by ELISA on immunogencoated plates.
Statistical Analyses
Quantitative data are presented as mean ± SD, unless otherwise mentioned. Statistical analyses were performed using GraphPad. Data were analyzed by paired or unpaired Student's t tests and, for multiple comparisons, either by one-way or two-way ANOVA or by t tests with the Bonferroni correction. Statistical significance of the differences observed between groups is defined as p < 0.05.
